Testing effectiveness (Phase 2)Study completedNCT01452815
What this trial is testing
Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
Who this might be right for
GastroparesisDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Tranzyme, Inc. 201